Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 67457-390

4 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 67457-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure diagram of zoledronic acid, showing its molecular framework including nitrogen-containing heterocyclic ring and phosphonate groups, consistent with the active ingredient zoledronic acid.*
FDA Label Image

Cockcroft-gault Formula (Image 02)

Cockcroft-gault Formula (Image 02)
A bar chart titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' comparing Zoledronic Acid Injection 4 mg (n=86) and Pamidronate 90 mg (n=99). The vertical axis shows the percentage of complete responders from 0% to 100%. Zoledronic Acid has a higher percentage of complete responders compared to Pamidronate, with a statistically significant difference (P=0.002).*
FDA Label Image

Figure 1 (Image 03)

Figure 1 (Image 03)
Packaging label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion, manufactured by Mylan Institutional LLC. The label states the product is sterile, for intravenous infusion after dilution, not for direct injection, and must not be mixed with calcium-containing infusion solutions. It includes storage instructions and active/inactive ingredient details, with NDC 67457-390-54, and the product is a single-dose vial.*
FDA Label Image

Carton Label 4 mg/5 mL (Image 04)

Carton Label 4 mg/5 mL (Image 04)
Packaging label for Zoledronic Acid Injection 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion. The label shows it is a sterile, single-dose vial requiring dilution before use and warns against direct injection or mixing with calcium-containing solutions. Manufactured for Mylan Institutional LLC, Morgantown, WV, and made in India. The label includes NDC 67457-390-54, storage instructions, and the Mylan logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.